This trial aims to use a novel personalized network analysis approach to elucidate the mechanisms of the effect of tDCS on cognitive dysfunction in non-demented PD patients.
- Parkinson's Disease
- Mild Cognitive Impairment
1 Primary · 0 Secondary · Reporting Duration: 1 month
2 Treatment Groups
Real tDCS right
1 of 2
1 of 2
36 Total Participants · 2 Treatment Groups
Primary Treatment: Real tDCS right · Has Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many participants are involved in this experimental research?
"Affirmative. Details on clinicaltrials.gov verify that this research study, which was submitted to the website on March 22nd 2017, is actively seeking participants. The trial requires 36 patients from a single medical facility to begin their investigation." - Anonymous Online Contributor
Is there still an opportunity to participate in this trial?
"The study, initially posted on March 22nd 2017, is actively recruiting patients as evidenced by data hosted on clinicaltrials.gov and most recently edited April 11th 2022." - Anonymous Online Contributor